Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kathleen P. L. Cheok"'
Autor:
Maeve A. O'Reilly, William Wilson, David Burns, Andrea Kuhnl, Frances Seymour, Ben Uttenthal, Caroline Besley, Rajesh Alajangi, Thomas Creasey, Shankara Paneesha, Johnathon Elliot, Carlos Gonzalez Arias, Sunil Iyengar, Matthew R. Wilson, Alison Delaney, Lourdes Rubio, Jonathan Lambert, Khalil Begg, Stephen Boyle, Kathleen P. L. Cheok, Graham P. Collins, Claire Roddie, Rod Johnson, Robin Sanderson
Publikováno v:
HemaSphere, Vol 8, Iss 6, Pp n/a-n/a (2024)
Abstract Brexucabtagene autoleucel (brexu‐cel) is an autologous CD19 CAR T‐cell product, approved for relapsed/refractory (r/r) mantle cell lymphoma (MCL). In ZUMA‐2, brexu‐cel demonstrated impressive responses in patients failing ≥2 lines,
Externí odkaz:
https://doaj.org/article/2580c990e3d748ad908ab8da5f93b054
Autor:
Maeve A. O'Reilly, Lorna Neill, Simon M. Collin, Neil Stone, Deborah Springell, Jeremy Mensah, Kathleen P. L. Cheok, Katarzyna Jalowiec, Reuben Benjamin, Andrea Kuhnl, Claire Roddie, Robin Sanderson
Publikováno v:
HemaSphere, Vol 8, Iss 1, Pp n/a-n/a (2024)
Abstract Infection has emerged as the chief cause of non‐relapse mortality (NRM) post CD19‐targeting chimeric antigen receptor T‐cell therapy (CAR‐T) therapy. Even though up to 50% of patients may remain infection‐free, many suffer multiple
Externí odkaz:
https://doaj.org/article/b2cae7a4b52d4e08b911dbd4be07370b
Autor:
Kathleen P. L. Cheok, Amy A. Kirkwood, Tobias Menne, Eleni Tholouli, Sridhar Chaganti, Amrith Mathew, Ben Uttenthal, James Russell, David Irvine, Rod Johnson, Emma Nicholson, Jessica Bazin, William Townsend, Andrea Kuhnl, Maeve O’Reilly, Robin Sanderson, Amit Patel, Claire Roddie
Publikováno v:
Leukemia & Lymphoma. 63:1980-1984